BR112012018626A2 - novo polimorfo de cloridrato de ester de (4-hdiroxicarbamoil-fenil)-acido carbâmico (6-dimetilamino metil-2-naftalenil) - Google Patents

novo polimorfo de cloridrato de ester de (4-hdiroxicarbamoil-fenil)-acido carbâmico (6-dimetilamino metil-2-naftalenil)

Info

Publication number
BR112012018626A2
BR112012018626A2 BR112012018626A BR112012018626A BR112012018626A2 BR 112012018626 A2 BR112012018626 A2 BR 112012018626A2 BR 112012018626 A BR112012018626 A BR 112012018626A BR 112012018626 A BR112012018626 A BR 112012018626A BR 112012018626 A2 BR112012018626 A2 BR 112012018626A2
Authority
BR
Brazil
Prior art keywords
hydroxycarbamoyl
naphthalenyl
phenyl
carbamic acid
ester hydrochloride
Prior art date
Application number
BR112012018626A
Other languages
English (en)
Other versions
BR112012018626B1 (pt
BR112012018626A8 (pt
Inventor
Maurizio Zenoni
Stefano Turchetta
Original Assignee
Chemi Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemi Spa filed Critical Chemi Spa
Publication of BR112012018626A2 publication Critical patent/BR112012018626A2/pt
Publication of BR112012018626A8 publication Critical patent/BR112012018626A8/pt
Publication of BR112012018626B1 publication Critical patent/BR112012018626B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

novo polimorfo de cloridrato de éster de (4-hidroxicarbamoil-fenil) - ácido carbâmico (6-dimetilamino metil-2-naftalenil). a se descreve uma nova forma cristalina do cloridrato de éster de (4-hidroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil). em particular, descreve-se aqui um polimorfo do cloridrato do éster do (4-hidroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil, caracterizado por um espectro de difração de raio x de pó como indicado na figura 1, e/ou por um perfil de dsc como indicado na figura 2, e/ou por um perfil de tga como indicado na figura 3 e/ou por um espectro de ir como indicado na figura 4.
BR112012018626-4A 2010-01-28 2010-12-03 Novo polimorfo de cloridrato do éster do (4-hdroxicarbamoil-fenil)-ácido carbâmico (6- dietilamino metil-2-naftalenil) BR112012018626B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A000121 2010-01-28
ITMI2010A000121A IT1397912B1 (it) 2010-01-28 2010-01-28 Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
PCT/IB2010/055560 WO2011092556A1 (en) 2010-01-28 2010-12-03 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester

Publications (3)

Publication Number Publication Date
BR112012018626A2 true BR112012018626A2 (pt) 2016-05-03
BR112012018626A8 BR112012018626A8 (pt) 2017-12-19
BR112012018626B1 BR112012018626B1 (pt) 2021-06-08

Family

ID=42288805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012018626-4A BR112012018626B1 (pt) 2010-01-28 2010-12-03 Novo polimorfo de cloridrato do éster do (4-hdroxicarbamoil-fenil)-ácido carbâmico (6- dietilamino metil-2-naftalenil)

Country Status (20)

Country Link
US (1) US8518988B2 (pt)
EP (1) EP2528599B1 (pt)
JP (1) JP2013518091A (pt)
KR (1) KR101723532B1 (pt)
CN (1) CN102665712B (pt)
AU (1) AU2010344330B2 (pt)
BR (1) BR112012018626B1 (pt)
CA (1) CA2780432C (pt)
CY (1) CY1115409T1 (pt)
DK (1) DK2528599T3 (pt)
ES (1) ES2489467T3 (pt)
HK (1) HK1175699A1 (pt)
HR (1) HRP20140610T1 (pt)
IT (1) IT1397912B1 (pt)
MX (1) MX2012008777A (pt)
PL (1) PL2528599T4 (pt)
PT (1) PT2528599E (pt)
RU (1) RU2552354C2 (pt)
SI (1) SI2528599T1 (pt)
WO (1) WO2011092556A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3871669A1 (en) * 2012-02-03 2021-09-01 Italfarmaco SpA Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
IT201900003281A1 (it) 2019-03-06 2020-09-06 Chemi Spa Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3574185B2 (ja) * 1994-09-02 2004-10-06 小松屋化学株式会社 無水クエン酸トリマグネシウムおよびその製法
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
AU1153097A (en) * 1996-06-07 1998-01-05 Eisai Co. Ltd. Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production
ITMI20030063A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
CA2603900A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
WO2007022488A2 (en) * 2005-08-16 2007-02-22 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
KR100830003B1 (ko) * 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
WO2009019205A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative

Also Published As

Publication number Publication date
PL2528599T3 (pl) 2014-10-31
PL2528599T4 (pl) 2014-11-28
CN102665712B (zh) 2013-10-16
KR20120123259A (ko) 2012-11-08
KR101723532B1 (ko) 2017-04-06
DK2528599T3 (da) 2014-06-30
HK1175699A1 (pt) 2013-07-12
EP2528599A1 (en) 2012-12-05
WO2011092556A1 (en) 2011-08-04
US8518988B2 (en) 2013-08-27
MX2012008777A (es) 2012-09-07
HRP20140610T1 (hr) 2014-08-15
RU2552354C2 (ru) 2015-06-10
JP2013518091A (ja) 2013-05-20
ITMI20100121A1 (it) 2011-07-29
RU2012134703A (ru) 2014-03-10
SI2528599T1 (sl) 2014-09-30
ES2489467T3 (es) 2014-09-02
CY1115409T1 (el) 2017-01-04
US20120302633A1 (en) 2012-11-29
AU2010344330B2 (en) 2014-11-13
IT1397912B1 (it) 2013-02-04
PT2528599E (pt) 2014-07-18
CA2780432A1 (en) 2011-08-04
BR112012018626B1 (pt) 2021-06-08
CA2780432C (en) 2017-02-21
AU2010344330A1 (en) 2012-05-24
EP2528599B1 (en) 2014-05-21
BR112012018626A8 (pt) 2017-12-19
CN102665712A (zh) 2012-09-12

Similar Documents

Publication Publication Date Title
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
ZA201401482B (en) Use of acylsulfonamides for improving plant yield
EP2593983B8 (en) Anode material, metal secondary battery, and method for production of anode material
HK1184492A1 (zh) 體細胞至誘導的重編程神經幹細胞 的轉化
EP2640403A4 (en) GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLASTIC STEM CELLS
MY158648A (en) Compositions for modulating a kinase cascade and methods of use thereof
BR112013007287A2 (pt) amidas oxopiperazina-azetidina e amidas oxodiazepina-azetina como inibidores de monoacilglicerol lipase
SG11202109034VA (en) Fermentative production of carbohydrates by microbial cells utilizing a mixed feedstock
TN2012000117A1 (en) Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
RS55521B1 (sr) Postupak za procenu osobina klijanja semena biljaka
IN2012DN01342A (pt)
EP2463266A4 (en) PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE
MX354280B (es) Hidrófobo de dibencilamina.
BR112012018626A2 (pt) novo polimorfo de cloridrato de ester de (4-hdiroxicarbamoil-fenil)-acido carbâmico (6-dimetilamino metil-2-naftalenil)
IN2012DN03846A (pt)
HK1216986A1 (zh) 反式降舍曲林的製劑、鹽和晶體形式及其應用
EP2465293A4 (en) TRANSFER METHOD FOR MINIMIZING DATA TREATED TO A TARGET NODE
CL2012000493A1 (es) Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.
IL210921A (en) Oral preparations of isoposporamide mustard salts for the treatment of aberrant cell growth
BR112012017828A2 (pt) ''método para a produção de um produto químico por fermentação contínua''
MX2011013057A (es) Metodo para producir derivado de benzotioamida 4-sustituida.
EP2192189A4 (en) PROCESS FOR THE PRODUCTION OF STARCHIC ACID
EP2527297A4 (en) METHOD FOR THE PRODUCTION OF ZINC TOLUENESULFONATE, ZINC TOLUENESULFONATE AND METHOD FOR THE PRODUCTION OF CARBAMATE
WO2010146595A3 (en) Novel polymorphs of flibanserin hydrochloride
FR2960450B1 (fr) Procede de production anaerobie d'hydrogene

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/12/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF